Literature DB >> 9705429

Discrimination of Burkholderia gladioli from other Burkholderia species detectable in cystic fibrosis patients by PCR.

A Bauernfeind1, I Schneider, R Jungwirth, C Roller.   

Abstract

A procedure for molecular identification of Burkholderia gladioli is described. Specific 16S and 23S rRNA gene signature sequences were defined as primers for PCR. The method allows rapid and specific discrimination of B. gladioli from related species (B. cepacia, B. multivorans, B. vietnamiensis, B. mallei, B. pseudomallei, Ralstonia pickettii, and R. eutropha) and should contribute to the clarification of its role as a human pathogen, e.g., in cystic fibrosis.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9705429      PMCID： PMC105199     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  A BACTERIAL DISEASE OF GLADIOLUS.

Authors:  L McCulloch
Journal:  Science       Date:  1921-08-05       Impact factor: 47.728

2.  Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium.

Authors:  D A Henry; M E Campbell; J J LiPuma; D P Speert
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

3.  Molecular procedure for rapid detection of Burkholderia mallei and Burkholderia pseudomallei.

Authors:  A Bauernfeind; C Roller; D Meyer; R Jungwirth; I Schneider
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

4.  Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis.

Authors:  J C Christenson; D F Welch; G Mukwaya; M J Muszynski; R E Weaver; D J Brenner
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

5.  Complete nucleotide sequence of a 16S ribosomal RNA gene from Escherichia coli.

Authors:  J Brosius; M L Palmer; P J Kennedy; H F Noller
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

6.  Taxonomy of the aerobic pseudomonads: Pseudomonas cepacia, P. marginata, P. alliicola and P. caryophylli.

Authors:  R W Ballard; N J Palleroni; M Doudoroff; R Y Stanier; M Mandel
Journal:  J Gen Microbiol       Date:  1970-02

7.  Isolation from clinical sources of Burkholderia cepacia possessing characteristics of Burkholderia gladioli.

Authors:  I A Baxter; P A Lambert; I N Simpson
Journal:  J Antimicrob Chemother       Date:  1997-02       Impact factor: 5.790

8.  Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.

Authors:  P Vandamme; B Holmes; M Vancanneyt; T Coenye; B Hoste; R Coopman; H Revets; S Lauwers; M Gillis; K Kersters; J R Govan
Journal:  Int J Syst Bacteriol       Date:  1997-10

9.  Cellular fatty acid composition of Pseudomonas marginata and closely associated bacteria.

Authors:  S B Dees; D G Hollis; R E Weaver; C W Moss
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

10.  Severe Burkholderia (Pseudomonas) gladioli infection in chronic granulomatous disease: report of two successfully treated cases.

Authors:  J P Ross; S M Holland; V J Gill; E S DeCarlo; J I Gallin
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079
View more
  16 in total

1.  Pseudomonas and all that.

Authors:  C A Hart; C Winstanley
Journal:  Arch Dis Child       Date:  1999-07       Impact factor: 3.791

2.  Identification of members of the Burkholderia cepacia complex by species-specific PCR.

Authors:  P W Whitby; K B Carter; K L Hatter; J J LiPuma; T L Stull
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

3.  Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex.

Authors:  Sylvain Brisse; Stefania Stefani; Jan Verhoef; Alex Van Belkum; Peter Vandamme; Wil Goessens
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

4.  Use of 16S rRNA gene sequencing for identification of nonfermenting gram-negative bacilli recovered from patients attending a single cystic fibrosis center.

Authors:  Agnes Ferroni; Isabelle Sermet-Gaudelus; Eric Abachin; Gilles Quesne; Gerard Lenoir; Patrick Berche; Jean-Louis Gaillard
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

Review 5.  Laboratory diagnosis of melioidosis: past, present and future.

Authors:  Susanna K P Lau; Siddharth Sridhar; Chi-Chun Ho; Wang-Ngai Chow; Kim-Chung Lee; Ching-Wan Lam; Kwok-Yung Yuen; Patrick C Y Woo
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-22

6.  Molecular procedure for rapid detection of Burkholderia mallei and Burkholderia pseudomallei.

Authors:  A Bauernfeind; C Roller; D Meyer; R Jungwirth; I Schneider
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

7.  Molecular typing and exopolysaccharide biosynthesis of Burkholderia cepacia isolates from a Portuguese cystic fibrosis center.

Authors:  J A Richau; J H Leitão; M Correia; L Lito; M J Salgado; C Barreto; P Cescutti; I Sá-Correia
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

8.  Species-specific PCR as a tool for the identification of Burkholderia gladioli.

Authors:  P W Whitby; L C Pope; K B Carter; J J LiPuma; T L Stull
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

9.  Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR.

Authors:  A Bauernfeind; I Schneider; R Jungwirth; C Roller
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

10.  Microbiological and epidemiological features of clinical respiratory isolates of Burkholderia gladioli.

Authors:  Christine Segonds; Patricia Clavel-Batut; Michelle Thouverez; Dominique Grenet; Alain Le Coustumier; Patrick Plésiat; Gérard Chabanon
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.